Company Description
LadRx (OTC Link: LADX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $579.3K.
LADX has declined 99.3% over the past year. Shares last traded at $0.0110.
For FY2024, LadRx reported net income of -$1.6M and diluted earnings per share of $-3.21.
This page collects what Stock Titan holds for LADX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LadRx (LADX) stock last closed at $0.0110. Over the past 12 months, the stock has lost 99.3%. At a market capitalization of $579.3K, LADX is classified as a micro-cap stock with approximately 495.1K shares outstanding.
LADX Rankings
Latest News
LadRx has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include stock split. View all LADX news →
SEC Filings
Financial Highlights
operating income reached -$3.6M, and net income was -$1.6M. Diluted earnings per share stood at $-3.21. The company generated -$1.3M in operating cash flow. With a current ratio of 0.37, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in LadRx (LADX) currently stands at 180 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for LadRx (LADX) currently stands at 2.0 days, down 63.7% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 98% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.5 days.
LADX Company Profile & Sector Positioning
LadRx (LADX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing LADX often look at related companies in the same sector, including Lobe Sciences (LOBEF), AIBotics (AIBT), Therapeutic Solutions Intl Inc (TSOI), Bio-Path Hldgs Inc (BPTH), and Emmaus Life Scie (EMMA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LADX's relative position within its industry.